UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

---

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 15, 2021

---

SC Health Corporation

(Exact name of registrant as specified in its charter)

---

+65 6438 1080

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

Explanatory Note

This Current Report on Form 8-K/A (the “Amendment”) is being filed to correct the percentage of the Class A ordinary shares that were redeemed for cash and the percentage of the Class A ordinary shares that remained outstanding after such redemption reported in the third paragraph of Item 5.07 of the Current Report on Form 8-K filed on April 14, 2021 (the “Original Filing”).

The Original Filing reported the percentage of the Class A ordinary shares that were redeemed for cash as 34.96%, and the percentage of the outstanding Class A ordinary shares that remained outstanding after such redemption as 65.04%.  Such percentages are being amended to report the percentage of the Class A ordinary shares that were redeemed for cash as 46.23%, and the percentage of the Class A ordinary shares that remained outstanding after such redemption as 53.77%.

This Amendment amends and restates the third paragraph of Item 5.07 in its entirety and does not otherwise amend, update, or change any other disclosures contained in the Original Filing.

In connection with the vote to approve the Extension Proposal, the holders of 7,975,485 Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.12 per share, for an aggregate redemption amount of approximately $80,711,908 million. As such, approximately 46.23% of the Class A ordinary shares were redeemed and approximately 53.77% of the Class A ordinary shares remain outstanding. After the satisfaction of such redemptions, the balance in the Company’s trust account will be approximately $93,835,584 million.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.